West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
12:31:05 2026-11-20 pm EST
|
5-day change | 1st Jan Change | ||
| 391.78 USD | -1.24% |
|
-6.02% | +42.24% |
| Market Cap | 27.63B 25.17B 23.19B 21.1B 39.58B 2,559B 41.59B 282B 112B 1,398B 104B 101B 4,386B | P/E 2026 * |
42.5x | P/E 2027 * | 38.2x |
|---|---|---|---|---|---|
| Enterprise Value | 27.14B 24.71B 22.77B 20.72B 38.86B 2,513B 40.84B 277B 110B 1,372B 102B 99.66B 4,307B | EV / Sales 2026 * |
7.93x | EV / Sales 2027 * | 7.4x |
| Free-Float |
92.02% | Yield 2026 * |
0.24% | Yield 2027 * | 0.26% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
| WST | Real-time | ||
| 0ADY | Delayed | ||
| WPS | Delayed | ||
| WPS | Real-time | ||
| WPS | Real-time | ||
| WPS | Delayed | ||
| WPS | End-of-day quote | ||
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -1.25% | ||
| 1 week | -6.02% | ||
| Current month | -5.15% | ||
| 1 month | +0.67% | ||
| 3 months | +10.63% | ||
| 6 months | +28.11% | ||
| Current year | +42.24% |
| 1 week | 387.71 | 420.66 | |
| 1 month | 381.98 | 438.27 | |
| Current year | 223.83 | 438.27 | |
| 1 year | 223.83 | 438.27 | |
| 3 years | 187.43 | 438.27 | |
| 5 years | 187.43 | 475 | |
| 10 years | 77.97 | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Other | Director | 44 | 0.0001% | ||
| 9/15/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 | Free | Chief Executive Officer | 51,798 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.24% | -6.02% | +51.83% | +12.13% | 27.63B | ||
| +0.24% | -3.88% | -15.86% | +3.07% | 180B | ||
| +0.63% | -1.36% | +2.12% | +34.99% | 123B | ||
| +0.38% | +1.74% | -12.61% | +8.89% | 119B | ||
| -1.24% | -4.25% | -43.89% | -1.12% | 89.18B | ||
| +0.67% | -4.16% | -4.97% | +75.60% | 65.12B | ||
| +0.89% | -1.33% | +13.47% | -7.94% | 57.93B | ||
| -0.96% | -2.72% | -0.62% | +44.86% | 54.33B | ||
| -2.91% | -5.00% | +0.37% | +35.13% | 48.88B | ||
| -1.64% | +1.50% | +2.30% | -1.14% | 36.07B | ||
| Average | -0.48% | -0.88% | -0.79% | +20.45% | 80B | |
| Weighted average by Cap. | -0.17% | -1.17% | -7.55% | +18.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42B 3.12B 2.87B 2.61B 4.9B 317B 5.15B 34.94B 13.89B 173B 12.83B 12.56B 543B | 3.62B 3.3B 3.04B 2.77B 5.19B 335B 5.45B 37B 14.71B 183B 13.59B 13.31B 575B |
| Net income | 666M 607M 559M 509M 954M 61.69B 1B 6.8B 2.7B 33.7B 2.5B 2.45B 106B | 735M 670M 617M 561M 1.05B 68.1B 1.11B 7.51B 2.99B 37.19B 2.76B 2.7B 117B |
| Net Debt | -499M -454M -419M -381M -714M -46.18B -751M -5.09B -2.02B -25.23B -1.87B -1.83B -79.17B | -836M -761M -701M -638M -1.2B -77.39B -1.26B -8.54B -3.39B -42.27B -3.14B -3.07B -133B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-20 | $391.43 | -1.33% | 171,213 |
| 26-11-19 | $396.69 | -1.81% | 819,624 |
| 26-11-18 | $404.02 | -2.44% | 595,823 |
| 26-11-17 | $414.12 | -0.88% | 494,112 |
| 26-11-16 | $417.80 | +0.33% | 526,156 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
















